CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance

CVS Health’s Caremark finalized an FTC settlement, agreeing to curb after-market rebate/discount practices and to count consumers’ TrumpRx purchases toward deductibles. The agreement signals tighter regulatory oversight of pharmacy benefit arrangements, which could pressure plan economics, though no financial magnitude was disclosed.

Analysis

CVS Health’s Caremark finalized an FTC settlement, agreeing to curb after-market rebate/discount practices and to count consumers’ TrumpRx purchases toward deductibles. The agreement signals tighter regulatory oversight of pharmacy benefit arrangements, which could pressure plan economics, though no financial magnitude was disclosed.